Arcadia Biosciences, Inc.
RKDA
$3.40
-$0.0813-2.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 62.09% | 56.73% | 65.37% | 9.07% | 24.70% |
| Total Depreciation and Amortization | -21.99% | -18.41% | -25.27% | -27.81% | -36.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -334.51% | -644.40% | -189.10% | 1,625.61% | -27.49% |
| Change in Net Operating Assets | -112.98% | -742.39% | -556.11% | -3,072.88% | 50.32% |
| Cash from Operations | 14.68% | 9.54% | -19.43% | -9.14% | 26.13% |
| Capital Expenditure | 48.39% | 48.39% | 43.75% | 93.06% | 76.87% |
| Sale of Property, Plant, and Equipment | 538.46% | 106.90% | -37.42% | -87.50% | -92.89% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 207.98% | 215.94% | -654.92% | -882.78% | -1,550.70% |
| Cash from Investing | 218.57% | 224.48% | -572.59% | -406.56% | -486.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.85% | -99.89% | -99.89% | 20.01% | 20.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 100.00% | -1.84% | -1.84% |
| Cash from Financing | -99.84% | -99.88% | -99.88% | 21.97% | 25.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.20% | -2.45% | -1,164.71% | -75.18% | 5.46% |
